Lazard Asset Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Lazard Asset Management LLC

  • $58.2 Billion
  • Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,553 shares of APLS stock, worth $67,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,553
Holding current value
$67,862
% of portfolio
0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$21.87 - $34.63 $77,704 - $123,040
3,553 New
3,553 $77,000
Q3 2024

Nov 14, 2024
SELL
$28.84 - $41.15 $86,318 - $123,161
-2,993 Reduced 48.31%
3,202 $92,000
Q2 2024

Aug 14, 2024
BUY
$38.07 - $59.71 $128,943 - $202,237
3,387 Added 120.62%
6,195 $237,000
Q1 2024

May 14, 2024
SELL
$55.39 - $72.47 $4.41 Million - $5.78 Million
-79,703 Reduced 96.6%
2,808 $165,000
Q4 2023

Feb 14, 2024
SELL
$37.14 - $64.82 $1.24 Million - $2.16 Million
-33,378 Reduced 28.8%
82,511 $4.94 Million
Q3 2023

Nov 14, 2023
BUY
$23.65 - $89.22 $2.48 Million - $9.35 Million
104,805 Added 945.55%
115,889 $4.41 Million
Q2 2023

Aug 14, 2023
SELL
$76.68 - $93.31 $1.86 Million - $2.26 Million
-24,220 Reduced 68.6%
11,084 $1.01 Million
Q1 2023

May 15, 2023
SELL
$46.59 - $66.96 $2.31 Million - $3.32 Million
-49,516 Reduced 58.38%
35,304 $2.33 Million
Q4 2022

Feb 14, 2023
BUY
$43.24 - $61.04 $1.67 Million - $2.36 Million
38,724 Added 84.01%
84,820 $4.39 Million
Q3 2022

Nov 14, 2022
BUY
$44.76 - $69.66 $1.52 Million - $2.37 Million
34,053 Added 282.76%
46,096 $3.15 Million
Q2 2022

Aug 09, 2022
BUY
$35.07 - $59.21 $328,255 - $554,205
9,360 Added 348.86%
12,043 $544,000
Q1 2022

May 13, 2022
BUY
$35.46 - $54.12 $95,139 - $145,203
2,683 New
2,683 $136,000
Q4 2021

Feb 09, 2022
SELL
$30.74 - $49.16 $37,994 - $60,761
-1,236 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$31.4 - $69.84 $38,810 - $86,322
1,236 New
1,236 $40,000
Q2 2021

Aug 12, 2021
SELL
$40.9 - $64.9 $54,151 - $85,927
-1,324 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$40.8 - $57.39 $484,091 - $680,932
-11,865 Reduced 89.96%
1,324 $56,000
Q4 2020

Feb 11, 2021
BUY
$30.79 - $57.2 $406,089 - $754,410
13,189 New
13,189 $754,000
Q4 2019

Feb 13, 2020
SELL
$22.1 - $30.8 $1.16 Million - $1.62 Million
-52,655 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$24.09 - $32.18 $1.27 Million - $1.69 Million
52,655 New
52,655 $1.27 Million

Others Institutions Holding APLS

# of Institutions
295
Shares Held
124M
Call Options Held
921K
Put Options Held
761K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $2.1B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email